| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 192 |
| 1 | BEVACIZUMAB | 44 |
| 2 | PREDNISONE | 40 |
| 3 | INFLIXIMAB | 29 |
| 4 | VEDOLIZUMAB | 26 |
| 5 | ERGOCALCIFEROL | 25 |
| 6 | OMEPRAZOLE MAGNESIUM | 25 |
| 7 | AZATHIOPRINE | 23 |
| 8 | ISOTRETINOIN | 23 |
| 9 | OMEPRAZOLE | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0263 |
| 1 | ERYTHROMYCIN LACTOBIONATE | 1 | 0.0068 |
| 2 | ERYTHROMYCIN AND BENZOYL PEROXIDE | 1 | 0.0062 |
| 3 | ANIDULAFUNGIN | 5 | 0.0031 |
| 4 | INFLIXIMAB-DYYB | 9 | 0.0026 |
| 5 | L-LYSINE | 1 | 0.0014 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 9 | 0.0011 |
| 7 | ERTAPENEM SODIUM | 8 | 0.0011 |
| 8 | OMEGA-3-ACID ETHYL ESTERS | 2 | 0.0010 |
| 9 | LEVOLEUCOVORIN INJECTION | 3 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 65 |
| 1 | Corticosteroid [EPC] | 64 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 49 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 47 |
| 4 | Proton Pump Inhibitor [EPC] | 32 |
| 5 | Platinum-based Drug [EPC] | 30 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 29 |
| 7 | Integrin Receptor Antagonist [EPC] | 28 |
| 8 | Vitamin C [EPC] | 28 |
| 9 | Benzodiazepine [EPC] | 27 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 1 | Provitamin D2 Compound [EPC] | 25 | 0.0008 |
| 2 | Echinocandin Antifungal [EPC] | 5 | 0.0006 |
| 3 | Bile Acid Sequestrant [EPC] | 5 | 0.0004 |
| 4 | Integrin Receptor Antagonist [EPC] | 28 | 0.0003 |
| 5 | Calcitonin [EPC] | 1 | 0.0003 |
| 6 | Chloride Channel Activator [EPC] | 3 | 0.0003 |
| 7 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 8 | Nitroimidazole Antimicrobial [EPC] | 20 | 0.0003 |
| 9 | Penem Antibacterial [EPC] | 10 | 0.0003 |